跳至主要内容
临床试验/ACTRN12622000753752
ACTRN12622000753752尚未招募未知

A pilot feasibility randomised controlled trial investigating the effect of viral transmission mitigation measures on the incidence of preterm birth in high-risk pregnant women.

Monash Medical Centre0 个研究点目标入组 100 人开始时间: 2022年5月26日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Female

入选标准

  • Pregnant women (singleton or multiple gestation) who are at ‘high risk’ of having a preterm birth where ‘high-risk’ will be defined as pregnant women who have had a previous preterm birth (<34 weeks), either spontaneously or due to iatrogenic delivery.

排除标准

  • We will exclude pregnant women carrying a foetus with one or more major congenital abnormalities.
  • We will exclude any pregnant women under the age of 18.
  • We will exclude pregnant women carrying a multiple gestation who have not had a previous preterm birth.

研究者

发起方
Monash Medical Centre

相似试验

Viral mitigation measures and preterm birth rate in... | 临床试验